Form 4: Gilead Sciences Executive Reports Stock Transaction
Insider Transaction (Form 4)
Wettan Keeley M Cain, EVP Gen Counsel, Legal & Comp of Gilead Sciences, Inc., reported multiple transactions in common stock on September 10, 2026.
Summary
- Option exercise/conversion: acquired 590 Common Stock on September 10, 2026; holds 9,044 after (Direct).
- Tax/exercise-price withholding: disposed of 285 Common Stock at $144.81 ($41,271) on September 10, 2026; holds 8,759 after (Direct).
- Option exercise/conversion: disposed of 590 Restricted Stock Unit on September 10, 2026; holds 13,405 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Wettan Keeley M Cain — Officer (EVP Gen Counsel, Legal & Comp)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-10 | Option exercise/conversion | Common Stock | 590 | — | — | 9,044 |
| 2026-09-10 | Tax/exercise-price withholding | Common Stock | 285 | $145 | $41.3K | 8,759 |
| 2026-09-10 | Option exercise/conversion | Restricted Stock Unit | 590 | — | — | 13,405 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-10 | Option exercise/conversion (590 shares) |
| 2026-09-10 | Tax/exercise-price withholding (285 shares) |
| 2026-09-10 | Option exercise/conversion (590 shares) |
Keywords
insider transaction, Form 4, GILD, GILEAD SCIENCES, INC., neutral, Wettan Keeley M Cain
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.